Clal Biotechnology Industries Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CBI
IL0011042806
Investment Holding Companies
Sales 2022 | 370K 100K | Sales 2023 | 104K 28.17K | Capitalization | 62.27M 16.87M |
---|---|---|---|---|---|
Net income 2022 | -61M -16.52M | Net income 2023 | -31M -8.4M | EV / Sales 2022 | 331 x |
Net Debt 2022 | 23.85M 6.46M | Net Debt 2023 | 22.4M 6.07M | EV / Sales 2023 | 814 x |
P/E ratio 2022 |
-1.6
x | P/E ratio 2023 |
-2.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.65% |
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 15-06-30 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 03-05-08 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 15-11-17 |
Gad Keren
BRD | Director/Board Member | 73 | 20-02-16 |
1st Jan change | Capi. | |
---|---|---|
+21.90% | 82.42B | |
+77.01% | 19.68B | |
+13.72% | 18.3B | |
+10.92% | 14.99B | |
+1.51% | 13.13B | |
+2.46% | 11.46B | |
+1.73% | 10.51B | |
-1.85% | 9.89B | |
+29.61% | 9.9B |